The Egyptian Drug Authority (EDA), represented by the Central Administration for Pharmaceutical Products, hereby announces the launch of a public consultation on the draft Notice to Applicants titled: "Submission Guidance for The Common Technical Document for Human Pharmaceutical Products (Version 6)".

We are honored to receive your comments and suggestions via the designated "Stakeholder Feedback Form" sent to the following email address: hdr.regua.acc@edaegypt.gov.eg

This consultation period is open from October 15, 2026, until October 29, 2026.

This initiative reflects the EDA's commitment to developing and unifying the mechanisms and procedures for submitting pharmaceutical product registration files in accordance with the Common Technical Document (CTD) system.

To review the draft Notice to Applicants, please click on the following link